Jeff Yass’s ANACOR PHARMACEUTICALS INC COM ANAC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q2
Sell
-101,038
Closed -$5.4M 10168
2016
Q1
$5.4M Buy
101,038
+12,695
+14% +$937K ﹤0.01% 2209
2015
Q4
$9.98M Buy
88,343
+43,053
+95% +$4.74M ﹤0.01% 1757
2015
Q3
$5.33M Sell
45,290
-436,252
-91% -$57M ﹤0.01% 2591
2015
Q2
$37.3M Buy
481,542
+163,911
+52% +$10.7M 0.02% 860
2015
Q1
$18.4M Buy
317,631
+231,784
+270% +$9.84M 0.01% 1299
2014
Q4
$2.77M Buy
85,847
+50,730
+144% +$1.52M ﹤0.01% 3865
2014
Q3
$859K Buy
35,117
+21,740
+163% +$442K ﹤0.01% 6221
2014
Q2
$237K Sell
13,377
-19,236
-59% -$310K ﹤0.01% 8792
2014
Q1
$653K Buy
32,613
+18,377
+129% +$356K ﹤0.01% 6282
2013
Q4
$239K Buy
14,236
+2,668
+23% +$36.9K ﹤0.01% 7977
2013
Q3
$123K Buy
+11,568
New +$101K ﹤0.01% 8011

Other funds holding ANAC

Jeff Yass's ANAC Position: Q2 2016 in Review

Jeff Yass sold out of ANACOR PHARMACEUTICALS INC COM (ANAC) in Q2 2016, closing a stake of 101,038 shares — an estimated $5.4M sold.

Jeff Yass first reported a position in ANAC in Q3 2013 and held it in 11 quarters. The position peaked at $37.3M in Q2 2015. 2 funds tracked by Wall St. Rank hold ANAC as of Q2 2016.

  • Jeff Yass reported no remaining ANACOR PHARMACEUTICALS INC COM position as of Q2 2016 after selling out during the quarter.
  • Jeff Yass sold 101,038 ANACOR PHARMACEUTICALS INC COM shares in Q2 2016, an estimated $5.4M.
  • Jeff Yass first reported a position in ANACOR PHARMACEUTICALS INC COM in Q3 2013 and held it in 11 quarters.
  • Jeff Yass's ANACOR PHARMACEUTICALS INC COM position peaked at $37.3M in Q2 2015.
  • 2 funds tracked by Wall St. Rank held ANACOR PHARMACEUTICALS INC COM as of Q2 2016.

Based on Susquehanna International Group's 13F filing for Q2 2016, filed 15 Aug 2016.